Serrano J, López-Pintor RM, Fernández-Castro M, Ramírez L, Sanz M, Casañas E, et al. Oral lesions in patients with primary Sjögren’s syndrome. A case-control cross-sectional study. Med Oral Patol Oral Cir Bucal. 2020 Jan 1;25 (1):e137-43.
doi:10.4317/medoral.23254
http://dx.doi.org/doi:10.4317/medoral.23254
1.
Medeiros CCG, Borges LGDA, Cherubini K, Salum FG, Silva, RMD, de
Figueiredo MAZ. Oral yeast colonization in patients with primary
and secondary Sjögren's syndrome. Oral Dis.
2018;24:1367-78. |
|
|||
|
||||
2.
Baer AN, Wallit B. Update on Sjögren syndrome and other causes of
sicca in older adults. Rheum Dis Clin North Am.
2018;44:419-36. |
|
|||
|
||||
3.
Mavragani CP, Moutsopoulos HM. The geoepidemiology of Sjögren's
syndrome. Autoimmun Rev.
2010;95:A305-10. |
|
|||
|
||||
4.
Tincani A, Andreoli L, Cavazzana I, Doria A, Favero M, Fenini MG,
et al. Novel aspects of Sjögren's syndrome in 2012. BMC Medicine.
2013;11:93. |
|
|||
|
||||
5.
Billings M, Amin Hadavand M, Alevizos I. Comparative analysis of
the 2016 ACR- EULAR and the 2002 AECG classification criteria for
Sjögren's syndrome: Findings from the NIH cohort. Oral Dis.
2017;24:184-90. |
|
|||
|
||||
6.
Vitali C, Bombardieri S, Jonsson R, Moutsopoulos H M, Alexander
EL, Carsons SE, Weisman MH. European classification criteria for
Sjögren's syndrome (SS). Classification criteria for Sjogren's
syndrome: A revised version of the European criteria proposed by
the American-European Consensus Group. Ann Rheum Dis.
2002;61:554-8. |
|
|||
|
||||
7.
Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M,
Lietman TM, et al. 2016 American College of Rheumatology/European
League Against Rheumatism classification criteria for primary
Sjögren's syndrome. A consensus and data-driven methodology
involving three international patient cohorts. ARD.
2016;76:9-16. |
|
|||
|
||||
8.
Ship JA, Fox PC, Baum BJ. How much saliva is enough? 'Normal'
function defined. JADA.
1991;122:63-9. |
|
|||
|
||||
9.
Márton K, Boros I, Varga G, Zelles T, Fejérdy P, Zeher M, Nagy
G. Evaluation of palatal flow rate and oral manifestations in
patients with Sjögren's syndrome. Oral Dis.
2006;12:480-6. |
|
|||
|
||||
10.
Patinen P, Aine L, Collin P, Hietanen J, Korpela M, Enckell G, et
al. Oral findings in coeliac and Sjögren's syndrome. Oral Dis.
2004;10:330-4. |
|
|||
|
||||
11.
Likar-Manookin K, Stewart C, Al-Hashimi I, Curtis W, Berg K,
Cherian K, et al. Prevalence of oral lesions of autoimmune
etiology in patients with primary Sjogren's syndrome. Oral Dis.
2013;19:598-603. |
|
|||
|
||||
12.
Pedersen AM, Reibel J, Nordgarden H, Bergem HO, Jensen JL,
Nauntofte B. Primary Sjögren's syndrome: salivary gland function
and clinical oral findings. Oral Dis.
1999;5:128-38 |
|
|||
|
||||
13.
Fernández Castro M, et al. Evaluación protocolizada odontológica
en el paciente con síndrome de Sjögren primario. Proyecto
EPOX-SSp: metodología y objetivos. Reumatol Clin.
2019. |
|
|||
|
||||
14.
Kramer IR, Pindborg JJ, Bezroukov V, Infirri, JS. World Health
Organization. Guide to epidemiology and diagnosis of oral mucosal
diseases and conditions. Comm Dent Oral Epidemiol.
1980;8:1-26. |
|
|||
|
||||
15.
López-Pintor RM, Hernández G, de Arriba L, de Andrés A.
Comparison of oral lesion prevalence in renal transplant patients
under immunosuppressive therapy and healthy controls. Oral Dis.
2010;16:89-95. |
|
|||
|
||||
16.
Blochowiak, K, Olewicz-Gawlik A, Polanska A, Nowak-Gabryel M,
Kocięcki J, Witmanowski, H, Sokalski J. Oral mucosal
manifestations in primary and secondary Sjögren syndrome and dry
mouth syndrome. Adv Dermatol Allergol.
2016;33:23-7. |
|
|||
|
||||
17.
Torres SR, Peixoto CB, Caldas DM, Silva EB, Akiti T, Nucci M, de
Uzeda M. Relationship between salivary flow rates and Candida
counts in subjects with xerostomia. Oral Sur Oral Med Oral Pathol
Oral Radiol.
2002;93:149-54. |
|
|||
|
||||
18.
Hsu S, Dickinson D. A new approach to Managing Oral Manifestations
of Sjögren's Syndrome and Skin Manifestations of Lupus. Biochem
Mol Biol.
2006;39:229-39. |
|
|||
|
||||
19.
Tapper-Jones L, Aldred M, Walker DM. Prevalence and intraoral
distribution of Candida albicans in Sjögren's syndrome. J Clin
Pathol.
1980;33:282-7. |
|
|||
|
||||
20.
Navazesh M. Methods for collecting saliva. Ann N Y Acad Sci.
1993;694:72-7. |
|
|||
|
||||
21.
Koseki M, Maki Y, Matsukubo T, Ohashi Y, Tsubota K. Salivary flow
and its relationship to oral signs and symptoms in patients with
dry eyes. Oral Dis.
2004;10:75-80. |
|
|||
|
||||
22. Olate S, Muñoz D, Neumann S, Pozzer L, Cavalieri-Pereira L, de Moraes M. A descriptive study of the oral status in subjects with Sjögren's syndrome. Int J Clin Exp Med. 2014;7:1140-4. |
|
|||
|
||||
23. Rhodus NL, Bloomquist C, Liljemark W, Bereuter J. Prevalence, density, and manifestations of oral Candida albicans in patients with Sjögren's syndrome. J Otolaryngol. 1997;26:300-5. |
|
|||
|
||||
24.
Yan Z, Young LA, Hua H, Xu Y. Multiple Oral Candida Infections in
Patients with Sjögren's syndrome- Prevalence and Clinical and
Drug Susceptibility Profiles. J Rheum.
2011;38:2428-31. |
|
|||
|
||||
25.
Lynge Pedersen A, Nauntofte B, Smidt, Torpet, L. Oral mucosal
lesions in older people: relation to salivary secretion, systemic
diseases and medications. Oral Dis.
2015;21:721-9. |
|
|||
|
||||
26.
Bergdahl M. Salivary flow and oral complaints in adult dental
patient. Community Dentistry and Oral Epidemiology.
2000;28:59-66. |
|
|||
|
||||
27.
Serrano J, López-Pintor, RM, González-Serrano J,
Fernández-Castro M, Casañas E, Hernández G. Oral lesions in
Sjögren's syndrome: a systematic review. Med Oral Patol Oral Cir
Bucal.
2018;23:e391-400. |
|
|||
|
||||
28.
Ergun S, Cekici A, Nursen Topcuoglu N, Migliari DA, Güven Külekçi
G, Tanyeri H, Isık G. Oral status and Candida colonization in
patients with Sjögren's Syndrome. Med Oral Patol Oral Cir Bucal.
2010;15:e310-5. |
|
|||
|
||||
29. Ferro F, Vagelli R, Bruni C, Cafaro G, Marcucci E, Bartolini E, Baldini C. One year in review 2016: Sjögren's syndrome. Clin Exp Rheumatol. 2016; 34:161-71. |
|
|||